Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile.
Open | $3.73 |
Close | - |
Volume / Avg. | 1.30M / 1.91M |
Day Range | $3.60 - $3.75 |
52 Wk Range | 3.40 - 11.69 |
Market Cap | $305.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 27.66% |
Days to Cover | 12.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR) and Zentalis Pharma (NASDAQ:ZNTL).
Editas Medicine has a consensus price target of $14.05.
The stock price for Editas Medicine (NASDAQ: EDIT) is $3.71 last updated September 23, 2024 at 2:50 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.